Company news
The development of the big data platform is accelerated by the completion of the $75 million B round financing of the Mi

   Shanghai, China, the United States, in Cambridge, Massachusetts and reykjavik, May 2, 2017 -- as a devoted to build large genome data standardization management platform of global genomics research and development services (CGO), WuXi group enterprise clear biological technology (WuXi NextCODE) today announced that the company has obtained from existing investors and partner institutions such as the $75 million B round of funding.

   The financing led by temasek and yunfeng capital, other investors including Amgen (Amgen) the risk of investment fund Amgen Ventures, and focus on greater China cross-border investment Partners, a private-equity firm 3 w. Clearly biotechnology on the chief executive officer (CEO) Hannes Mr Smarason said: "we are committed to building the world's leading genome data management platform, promote gene sequence data of large scale, to promote human health. The rapid growth of our business is driving the development of a number of national precision medicine programs, gene diagnostics and health services across the globe.

   Clearly biotechnology on the chief executive officer (CEO) Hannes Mr Smarason said: "we are committed to building the world's leading genome data management platform, promote gene sequence data of large scale, to promote human health. The rapid growth of our business is driving the development of a number of national precision medicine programs, gene diagnostics and health services across the globe.

   "Genomics is the perfect fusion of life science and big data," wuxi group's founder and chairman of the board of directors is also a clear biotechnology chairman Dr Li Ge said, "clearly biotechnology has digital, management, and analysis on the application of genome data comprehensive ability, its unique positioning technology platform to build open data and ability, make any organization or individual can benefit from genome big data."

   Biotechnology will clearly to the financing as an opportunity to focus on promoting the commercialization of the Chinese consumer market solution process, strengthen its leadership position in the field of bioinformatics, further development of artificial intelligence and the ability of deep learning.

About Ming code biotechnology.(WuXi NextCODE)

Copyright © 2017 Huapeng. All rights reserved
技术支持:英铭长沙网站建设
Telephone:0731-82850025
Tencent QQ:654352163

WeChat

XXh51648

技术支持 英铭科技